carbapenems has been researched along with Bile Duct Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, XN; Kong, HS; Lai, MC; Shi, SH; Zheng, SS | 1 |
| Igarashi, Y; Inui, K; Ohara, H; Ohya, T; Tazuma, S; Tsuyuguchi, T | 1 |
| Cacciarelli, TV; Muder, RR; Shields, RK; Singh, N; Sun, HY | 1 |
1 trial(s) available for carbapenems and Bile Duct Diseases
| Article | Year |
|---|---|
Clinical efficacy of intravenous ciprofloxacin in patients with biliary tract infection: a randomized controlled trial with carbapenem as comparator.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Bile Duct Diseases; Carbapenems; Ciprofloxacin; Drug Evaluation; Female; Humans; Infusions, Intravenous; Male | 2009 |
2 other study(ies) available for carbapenems and Bile Duct Diseases
| Article | Year |
|---|---|
Biliary diseases as main causes of pyogenic liver abscess caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Bile Duct Diseases; Carbapenems; China; Escherichia coli; Female; Humans; Klebsiella pneumoniae; Liver Abscess, Pyogenic; Logistic Models; Male; Middle Aged; Retrospective Studies; Young Adult | 2017 |
A novel combination regimen for the treatment of refractory bacteremia due to multidrug-resistant Pseudomonas aeruginosa in a liver transplant recipient.
Topics: Anti-Bacterial Agents; Bacteremia; Bile Duct Diseases; Carbapenems; Colistin; Doripenem; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Liver Transplantation; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Treatment Outcome | 2010 |